122 Results

People

  1. Brennan
    Brennan
  2. O'Reilly
    O'Reilly
  3. Jarnagin
    Jarnagin
  4. Klimstra
    Klimstra
  5. D'Angelica
    D'Angelica
  6. Gonen
    Gonen
  7. Balachandran
    Balachandran
  8. Kingham
    Kingham
  9. Soares
    Soares
  10. Fong
    Fong

Groups

  1. Center for Pancreatic Cancer Research (67)
  2. Surgery (49)
  3. Department of Medicine (42)
  4. Solid Tumor Oncology Division (36)
  5. Sloan Kettering Institute Faculty (33)
  6. GSK Faculty (31)
  7. Gastrointestinal Oncology Service (31)
  8. Department of Pathology and Laboratory Medicine (28)
  9. Molecular Pharmacology and Chemistry Program Faculty (27)
  10. Sloan Kettering Institute Postdocs (26)
  1. "pancreas carcinoma"
Formats
  1. Journal Article (115)
  2. Conference Paper (2)
  3. Editorial (2)
  4. Guidelines (2)
  5. Review (1)
Groups
  1. Center for Pancreatic Cancer Research (67)
  2. Surgery (49)
  3. Department of Medicine (42)
  4. Solid Tumor Oncology Division (36)
  5. Sloan Kettering Institute Faculty (33)
  6. GSK Faculty (31)

More Groups

People
  1. David Klimstra (31)
  2. Eileen O'Reilly (23)
  3. Murray Brennan (23)
  4. William Jarnagin (20)
  5. Michael D'Angelica (17)
  6. Mithat Gonen (12)

More People

Years
  1. 2024 (4)
  2. 2023 (23)
  3. 2022 (13)
  4. 2021 (2)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. American Journal of Surgical Pathology (9)
  2. Annals of Surgery (7)
  3. Cancer (7)
  4. Clinical Cancer Research (6)
  5. Archives of Surgery (4)
  6. International Journal of Radiation Oncology, Biology, Physics (4)

More Publications

Publishers
  1. Lippincott Williams & Wilkins (22)
  2. Elsevier Inc. (14)
  3. Wiley Blackwell (14)
  4. American Association for Cancer Research (12)
  5. Springer (8)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (122)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intermittent MEK inhibition with GITR costimulation rescues T-cell function for increased efficacy with CTLA-4 blockade in solid tumor models
    Journal Article

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mangarin, L. M.; Nevarro, V. E.; Mehanna, N.; Khan, J. F.; Venkatesh, D.; more...
    Cancer Immunology Research (2024)

    Fulltext@MSK | Save
  • SWI/SNF complex-deficient undifferentiated carcinoma of the pancreas: Clinicopathologic and genomic analysis
    Journal Article

    Yavas, A.; Ozcan, K.; Adsay, N. V.; Balci, S.; Tarcan, Z. C.; Hechtman, J. F.; Luchini, C.; Scarpa, A.; Lawlor, R. T.; Mafficini, A.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Analysis of radiation therapy quality assurance in NRG oncology RTOG 0848
    Journal Article

    Tchelebi, L. T.; Winter, K. A.; Abrams, R. A.; Safran, H. P.; Regine, W. F.; McNulty, S.; Wu, A.; Du, K. L.; Seaward, S. A.; Bian, S. X.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes in pancreatic cancer: A comparative analysis of Ontario and the USA
    Journal Article

    Saadat, L. V.; Schofield, E.; Bai, X.; Curry, M.; Saskin, R.; Lipitz-Snyderman, A.; Soares, K. C.; Kingham, T. P.; Jarnagin, W. R.; D’Angelica, M. I.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up☆
    Guidelines

    Conroy, T.; Pfeiffer, P.; Vilgrain, V.; Lamarca, A.; Seufferlein, T.; O'Reilly, E. M.; Hackert, T.; Golan, T.; Prager, G.; Haustermans, K.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Genomic profiling reveals germline predisposition and homologous recombination deficiency in pancreatic acinar cell carcinoma
    Journal Article

    Mandelker, D.; Marra, A.; Zheng-Lin, B.; Selenica, P.; Blanco-Heredia, J.; Zhu, Y.; Gazzo, A.; Wong, D.; Yelskaya, Z.; Rai, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): A randomised, open-label, phase 3 trial
    Journal Article

    Wainberg, Z. A.; Melisi, D.; Macarulla, T.; Pazo Cid, R.; Chandana, S. R.; De La Fouchardière, C.; Dean, A.; Kiss, I.; Lee, W. J.; Goetze, T. O.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • Real-time 4D MRI using MR signature matching (MRSIGMA) on a 1.5T MR-Linac system
    Journal Article

    Wu, C.; Murray, V.; Siddiq, S. S.; Tyagi, N.; Reyngold, M.; Crane, C.; Otazo, R.
    Physics in Medicine and Biology (2023)

    Fulltext@MSK | Save
  • KRAS(G12D) inhibition in pancreatic cancer: Fas expression facilitates immune clearance
    Editorial

    Yeh, C.; Park, W.; Yaeger, R.
    Developmental Cell (2023)

    Fulltext@MSK | Save
  • Genetic susceptibility to nonalcoholic fatty liver disease and risk for pancreatic cancer: Mendelian randomization
    Journal Article

    King, S. D.; Veliginti, S.; Brouwers, M. C. G. J.; Ren, Z.; Zheng, W.; Setiawan, V. W.; Wilkens, L. R.; Shu, X. O.; Arslan, A. A.; Beane Freeman, L. E.; more...
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save